World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Spring Sale: Get 35% off with a min. purchase of 2 titles. Use code SPRING35. Valid till 31st Mar 2025.

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
https://doi.org/10.1142/9781786344946_0026Cited by:0 (Source: Crossref)
Abstract:

The following sections are included:

  • Understanding of the nomenclature used for the classification of vasospastic disorders into primary and secondary Raynaud’s phenomena (RP) is essential.

  • The management of these disorders requires a multidisciplinary team approach involving physicians, rheumatologists and vascular specialists.

  • Treatment of Raynaud’s includes general supportive measures, pharmacotherapy and correction of underlying disorders.

  • Vasculitis is associated with a range of medical conditions and can present as digital ischaemia.

  • A diagnosis of vasculitis is suggested by constitutional symptoms and confirmed by raised inflammatory markers, the presence of autoantibodies, targeted radiological imaging and biopsy of skin lesions or other involved organs.

  • Immunosuppressive therapy is the mainstay of treatment in vasculitic disorders.